Outsource high-potency ADC manufacturing to specialized CDMOs to reduce capital investment, access containment infrastructure, and accelerate clinical-to-commercial scale-up.Dublin, Oct. (GLOBE ...
Medical cannabis active pharmaceutical ingredient manufacturer NeoCannBio signed a memorandum of understanding on October 12, ...
A newly released Bentham Books volume examines how eutectic mixtures can enhance the solubility, dissolution, and ...
MitoCareX enhances bioinformatics capabilities to improve disease analysis in drug discovery processes through expert ...
Axis Direct initiates coverage on Aarti Drugs with a BUY rating and a target of Rs 454, fueled by capacity expansion and ...
OpenAI's API pricing page has quietly added an unannounced life sciences model called gpt-rosalind-discovery, priced identically to the ...
Wanbury Limited continued to expand business opportunities by filing new Drug Master File (DMF) in South Africa for Tramadol ...
Wanbury Ltd expands API portfolio with new DMF filings and regulatory approvals from EDQM and TGA, boosting its market access in international regions.
A total of 38 areas recorded unhealthy Air Pollutant Index readings as of 9 am today, with Segamat, Johor the highest at 187, ...
ST Pharm is pitching for oligonucleotide CDMO orders at CPHI Worldwide 2026 in Milan, meeting global pharma and biotech firms ...
Huahai Pharmaceutical has issued the first third-quarter earnings preview among China A-share listed drugmakers, projecting attributable net profit ...
According to MarketsandMarkets™, the Active Pharmaceutical Ingredients (API) Market is projected to reach USD 199.42 billion by 2031 from USD 149.02 billion in 2026, at a CAGR of 6.0% during the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results